H01
Covers the major ApoE polymorphisms rs429358 and rs7412..
ApoE
ApoE genotyping assay for the analysis of genetic variants associated with Alzheimer's disease and cardiovascular health. Designed for efficient sample processing and reliable genotype determination.
H01
Covers the major ApoE polymorphisms rs429358 and rs7412..
H02
Direct amplification from oral swab samples.
H03
Automated analysis using standard real-time PCR instruments.
ApoE genotyping provides genetic insights related to lipid metabolism, cardiovascular health, and Alzheimer's disease (AD) risk, supporting personalized health management and research applications.
Covers ApoE rs429358 and rs7412 genotyping.
Dual-channel fluorescent probe assay for accurate genotype determination.
Extraction-free workflow with direct amplification from oral swab samples.
Supports cardiovascular and Alzheimer's disease (AD) research applications.
Apolipoprotein | ApoE4 | ApoE3 | ApoE2 |
|---|---|---|---|
Negative | ε4/ε4, ε3/ε4 | ε2/ε4, ε3/ε3 | ε2/ε3, ε2/ε2 |
Population proportion | 10%-15% | 70%-80% | 5%-10% |
Atorvastatin | Low response | Responsive | Responsive |
Pravastatin | Low response | Responsive | Responsive |
Lovastatin | Low response | Responsive | Responsive |
Rosuvastatin | Low response | Responsive | Responsive |
Fluvastatin | Low response | Responsive | Responsive |
Simvastatin | Responsive | Responsive | Low response |
Probucol | Responsive | Responsive | Low response |
Alzheimer's disease | Higher risk | Normal | Lower risk |
Reference: Expert consensus on SLCO1B1 and ApoE polymorphism testing and clinical application of statins. Chinese Journal of Laboratory Medicine, 2023, 46(7):672-680.
Get personalized guidance from our technical experts to help solve complex research challenges, so you can stay focused on your science.
01
02
Call our team Mon–Fri from 8am to 5pm.